Clinical trial
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell…
NCT00002594 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002594 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors |
| Official title | Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Tumor, Central Nervous System Tumor |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Sargramostim, cyclophosphamide, melphalan, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Enrollment | 31 |
| Start date | Sep 1, 1994 |
| Primary completion | Sep 1, 2003 |
| Completion | Mar 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 24, 2014 |
| Countries | Australia, Canada, Netherlands, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: